Advice
Following a full submission
Cytarabine liposomal suspension for injection (Depocyte) is not recommended for use within NHS Scotland for the intrathecal treatment of lymphomatous meningitis.
Intrathecally administered cytarabine liposomal suspension cleared malignant cells from the cerebrospinal fluid, however effects on symptom improvement were not well defined and the cost-effectiveness compared to cytarabine solution has not been demonstrated.
Download detailed advice49KB (PDF)
Medicine details
- Medicine name:
- liposomal cytarabine 50mg suspension for injection (Depocyte®)
- SMC ID:
- 164/05
- Indication:
- Intrathecal treatment of lymphomatous meningitis
- Pharmaceutical company
- Napp Pharmaceuticals Ltd
- BNF chapter
- Malignant disease and immunosuppression
- Submission type
- Full
- Status
- Not recommended
- Date advice published
- 09 May 2005